Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index

Publisher： Karger

E-ISSN： 1423-0232|55|5|405-415

ISSN： 0030-2414

Source： Oncology, Vol.55, Iss.5, 1998-08, pp. : 405-415

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apoptosis-Regulating Proteins and Prognosis in Diffuse Large B Cell Non-Hodgkin’s Lymphomas

By  

Acta Haematologica, Vol. 107, Iss. 1, 2002-01 ,pp. : 29-34

Karger

Access to resources Recommend Favorite

Renal Involvement of Non-Hodgkin’s Lymphoma and Its Prognostic Effect in Childhood

By  

Nephron Clin Pract, Vol. 100, Iss. 3, 2005-04 ,pp. : c86-c91

Karger

Access to resources Recommend Favorite

Rituximab in Combination with Interferon-Alpha in Relapsed and Refractory Diffuse Large B-Cell Non-Hodgkin’s Lymphoma

By  

Acta Haematologica, Vol. 106, Iss. 3, 2001-11 ,pp. : 141-142

Karger

Access to resources Recommend Favorite

Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole‐body volumetric–metabolic FDG‐PET/CT metrics in diffuse large B‐cell lymphoma

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 6, 2015-06 ,pp. : 532-539

John Wiley & Sons Inc

Access to resources Recommend Favorite

Isolation of Side Population Cells in B-Cell Non-Hodgkin’s Lymphomas

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-09 ,pp. : 10-17

Karger

Access to resources Recommend Favorite